Connection

David Potter to Norepinephrine

This is a "connection" page, showing publications David Potter has written about Norepinephrine.
Connection Strength

0.899
  1. Kappa opioid agonist-induced changes in IOP: correlation with 3H-NE release and cAMP accumulation. Exp Eye Res. 2001 Aug; 73(2):167-78.
    View in: PubMed
    Score: 0.175
  2. Potential mechanisms of moxonidine-induced ocular hypotension: role of norepinephrine. J Ocul Pharmacol Ther. 1997 Dec; 13(6):489-96.
    View in: PubMed
    Score: 0.136
  3. Moxonidine-induced inhibition of norepinephrine release in monkey and rabbit ciliary bodies: role of cGMP. Pharmacology. 1997 Oct; 55(4):211-6.
    View in: PubMed
    Score: 0.134
  4. Changes in muscle proteins and spermidine content in response to unloading and clenbuterol treatment. Can J Physiol Pharmacol. 2003 Jan; 81(1):28-39.
    View in: PubMed
    Score: 0.048
  5. Ocular hypotension induced by electroacupuncture. J Ocul Pharmacol Ther. 2002 Aug; 18(4):293-305.
    View in: PubMed
    Score: 0.047
  6. Naphazoline-induced neuroendocrine changes: increases in ANP and cGMP levels, but suppression of NE, 3H-NE, and cAMP levels in rabbit eyes. Pharmacology. 2002 Jul; 65(3):155-61.
    View in: PubMed
    Score: 0.047
  7. Potential sites of action of TNPA: a dopamine-2 receptor agonist. Exp Eye Res. 1999 Dec; 69(6):611-6.
    View in: PubMed
    Score: 0.039
  8. 8OH-DPAT-Induced ocular hypotension: sites and mechanisms of action. Exp Eye Res. 1999 Aug; 69(2):227-38.
    View in: PubMed
    Score: 0.038
  9. Intraocular pressure lowering by S-allylmercaptocysteine in rabbits. J Ocul Pharmacol Ther. 1999 Feb; 15(1):9-17.
    View in: PubMed
    Score: 0.037
  10. Lisuride acts at multiple sites to induce ocular hypotension and mydriasis. Pharmacology. 1998 Nov; 57(5):249-60.
    View in: PubMed
    Score: 0.036
  11. Rilmenidine-induced ocular hypotension: role of imidazoline1 and alpha 2 receptors. Curr Eye Res. 1996 Sep; 15(9):943-50.
    View in: PubMed
    Score: 0.031
  12. Alpha-2 adrenoceptor mediated changes in aqueous dynamics: effect of pertussis toxin. Exp Eye Res. 1994 Jun; 58(6):729-36.
    View in: PubMed
    Score: 0.027
  13. Ocular hypotensive action of a dopaminergic (DA2) agonist, 2,10,11-trihydroxy-N-n-propylnoraporphine. J Pharmacol Exp Ther. 1993 Nov; 267(2):822-7.
    View in: PubMed
    Score: 0.026
  14. Allicin-induced hypotension in rabbit eyes. J Ocul Pharmacol. 1993; 9(3):201-9.
    View in: PubMed
    Score: 0.024
  15. Ocular inhibitory effects of the dopamine DA2 agonist (Ha-118) in cats and rabbits. J Auton Pharmacol. 1990 Jun; 10(3):153-61.
    View in: PubMed
    Score: 0.020
  16. Forskolin suppresses sympathetic neuron function and causes ocular hypotension. Curr Eye Res. 1985 Feb; 4(2):87-96.
    View in: PubMed
    Score: 0.014
  17. Steric structure activity relationships of various adrenergic agonists: ocular and systemic effects. Curr Eye Res. 1981; 1(1):25-35.
    View in: PubMed
    Score: 0.011
  18. Changes in plasma glucose and insulin levels induced by adrenergic agents in normal and alloxan-diabetic rats. Proc Soc Exp Biol Med. 1977 Mar; 154(3):337-40.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.